Anemia Explained

Anemia
Synonyms:Anaemia, erythrocytopenia
Field:Hematology
Symptoms:Feeling tired, pale skin, weakness, shortness of breath, feeling faint[1]
Causes:Blood loss, decreased red blood cell production, increased red blood cell breakdown
Diagnosis:Blood hemoglobin measurement
Frequency:2.36 billion / 33% (2015)

Anemia or anaemia (British English) is a blood disorder in which the blood has a reduced ability to carry oxygen. This can be due to a lower than normal number of red blood cells, a reduction in the amount of hemoglobin available for oxygen transport, or abnormalities in hemoglobin that impair its function.[2] [3]

The name is derived .[4] When anemia comes on slowly, the symptoms are often vague, such as tiredness, weakness, shortness of breath, headaches, and a reduced ability to exercise.[1] When anemia is acute, symptoms may include confusion, feeling like one is going to pass out, loss of consciousness, and increased thirst.[1] Anemia must be significant before a person becomes noticeably pale.[1] Additional symptoms may occur depending on the underlying cause. Anemia can be temporary or long term and can range from mild to severe.[5]

Anemia can be caused by blood loss, decreased red blood cell production, and increased red blood cell breakdown.[1] Causes of blood loss include bleeding due to inflammation of the stomach or intestines, bleeding from surgery, serious injury, or blood donation.[1] Causes of decreased production include iron deficiency, folate deficiency, vitamin B12 deficiency, thalassemia and a number of bone marrow tumors.[1] Causes of increased breakdown include genetic disorders such as sickle cell anemia, infections such as malaria, and certain autoimmune diseases.[1]

Anemia can also be classified based on the size of the red blood cells and amount of hemoglobin in each cell.[1] If the cells are small, it is called microcytic anemia; if they are large, it is called macrocytic anemia; and if they are normal sized, it is called normocytic anemia.[1] The diagnosis of anemia in men is based on a hemoglobin of less than 130 to 140 g/L (13 to 14 g/dL); in women, it is less than 120 to 130 g/L (12 to 13 g/dL).[1] [6] Further testing is then required to determine the cause.[1] [7]

Treatment depends on the specific cause. Certain groups of individuals, such as pregnant women, can benefit from the use of iron pills for prevention.[1] [8] Dietary supplementation, without determining the specific cause, is not recommended.[1] The use of blood transfusions is typically based on a person's signs and symptoms.[1] In those without symptoms, they are not recommended unless hemoglobin levels are less than 60 to 80 g/L (6 to 8 g/dL).[1] These recommendations may also apply to some people with acute bleeding.[1] Erythropoiesis-stimulating agents are only recommended in those with severe anemia.[9]

Anemia is the most common blood disorder, affecting about a fifth to a third of the global population.[1] [10] [11] [12] Iron-deficiency anemia is the most common cause of anemia worldwide, and affects nearly one billion people.[13]

In 2013, anemia due to iron deficiency resulted in about 183,000 deaths – down from 213,000 deaths in 1990.[14] This condition is most prevalent in children[15] with also an above average prevalence in elderly[1] and women of reproductive age (especially during pregnancy). Anemia is one of the six WHO global nutrition targets for 2025 and for diet-related global targets endorsed by World Health Assembly in 2012 and 2013. Efforts to reach global targets contribute to reaching Sustainable Development Goals (SDGs),[16] with anemia as one of the targets in SDG 2 for achieving zero world hunger.[17]

Signs and symptoms

A person with anemia may not have any symptoms, depending on the underlying cause, and no symptoms may be noticed, as the anemia is initially mild, and then the symptoms become worse as the anemia worsens. A patient with anemia may report feeling tired, weak, decreased ability to concentrate, and sometimes shortness of breath on exertion.[18] These symptoms are unspecific and none of the symptoms alone or in combination show a good predictive value for the presence of anemia in non-clinical patients.[19]

Symptoms of anemia can come on quickly or slowly.[20] Early on there may be few or no symptoms. If the anemia continues slowly (chronic), the body may adapt and compensate for this change. In this case, no symptoms may appear until the anemia becomes more severe.[21] Symptoms can include feeling tired, weak, dizziness, headaches, intolerance to physical exertion, shortness of breath, difficulty concentrating, irregular or rapid heartbeat, cold hands and feet, cold intolerance, pale or yellow skin, poor appetite, easy bruising and bleeding, and muscle weakness.

Anemia that develops quickly, often, has more severe symptoms, including, feeling faint, chest pain, sweating, increased thirst, and confusion.[22] [23] [24] There may be also additional symptoms depending on the underlying cause.[1]

In more severe anemia, the body may compensate for the lack of oxygen-carrying capability of the blood by increasing cardiac output. The person may have symptoms related to this, such as palpitations, angina (if pre-existing heart disease is present), intermittent claudication of the legs, and symptoms of heart failure.[25]

On examination, the signs exhibited may include pallor (pale skin, mucosa, conjunctiva and nail beds), but this is not a reliable sign. A blue coloration of the sclera may be noticed in some cases of iron-deficiency anemia.[26] There may be signs of specific causes of anemia, e.g. koilonychia (in iron deficiency), jaundice (when anemia results from abnormal break down of red blood cells – in hemolytic anemia), nerve cell damage (vitamin B12 deficiency), bone deformities (found in thalassemia major) or leg ulcers (seen in sickle-cell disease). In severe anemia, there may be signs of a hyperdynamic circulation: tachycardia (a fast heart rate), bounding pulse, flow murmurs, and cardiac ventricular hypertrophy (enlargement). There may be signs of heart failure.Pica, the consumption of non-food items such as ice, paper, wax, grass, hair or dirt, may be a symptom of iron deficiency;[27] although it occurs often in those who have normal levels of hemoglobin.Chronic anemia may result in behavioral disturbances in children as a direct result of impaired neurological development in infants, and reduced academic performance in children of school age. Restless legs syndrome is more common in people with iron-deficiency anemia than in the general population.[28]

Causes

The causes of anemia may be classified as impaired red blood cell (RBC) production, increased RBC destruction (hemolytic anemia), blood loss and fluid overload (hypervolemia). Several of these may interplay to cause anemia. The most common cause of anemia is blood loss, but this usually does not cause any lasting symptoms unless a relatively impaired RBC production develops, in turn, most commonly by iron deficiency.[3]

Impaired production

Increased destruction

Anemias of increased red blood cell destruction are generally classified as hemolytic anemias. These types generally feature jaundice, and elevated levels of lactate dehydrogenase.[32] [33]

Blood loss

The roots of the words anemia and ischemia both refer to the basic idea of "lack of blood", but anemia and ischemia are not the same thing in modern medical terminology. The word anemia used alone implies widespread effects from blood that either is too scarce (e.g., blood loss) or is dysfunctional in its oxygen-supplying ability (due to whatever type of hemoglobin or erythrocyte problem). In contrast, the word ischemia refers solely to the lack of blood (poor perfusion). Thus ischemia in a body part can cause localized anemic effects within those tissues.[44]

Fluid overload

Fluid overload (hypervolemia) causes decreased hemoglobin concentration and apparent anemia:[45]

Intestinal inflammation

Certain gastrointestinal disorders can cause anemia. The mechanisms involved are multifactorial and not limited to malabsorption but mainly related to chronic intestinal inflammation, which causes dysregulation of hepcidin that leads to decreased access of iron to the circulation.[48] [49]

Diagnosis

Definitions

There are a number of definitions of anemia; reviews provide comparison and contrast of them.[56] A strict but broad definition is an absolute decrease in red blood cell mass, however, a broader definition is a lowered ability of the blood to carry oxygen.[57] An operational definition is a decrease in whole-blood hemoglobin concentration of more than 2 standard deviations below the mean of an age- and sex-matched reference range.[58]

It is difficult to directly measure RBC mass,[59] so the hematocrit (amount of RBCs) or the hemoglobin (Hb) in the blood are often used instead to indirectly estimate the value.[60] Hematocrit; however, is concentration dependent and is therefore not completely accurate. For example, during pregnancy a woman's RBC mass is normal but because of an increase in blood volume the hemoglobin and hematocrit are diluted and thus decreased. Another example would be bleeding where the RBC mass would decrease but the concentrations of hemoglobin and hematocrit initially remains normal until fluids shift from other areas of the body to the intravascular space.

The anemia is also classified by severity into mild (110 g/L to normal), moderate (80 g/L to 110 g/L), and severe anemia (less than 80 g/L) in adults.[61] Different values are used in pregnancy and children.[61]

Testing

Anemia is typically diagnosed on a complete blood count. Apart from reporting the number of red blood cells and the hemoglobin level, the automatic counters also measure the size of the red blood cells by flow cytometry, which is an important tool in distinguishing between the causes of anemia. Examination of a stained blood smear using a microscope can also be helpful, and it is sometimes a necessity in regions of the world where automated analysis is less accessible.

WHO's Hemoglobin thresholds used to define anemia[62] (1 g/dL = 0.6206 mmol/L)
Age or gender groupHb threshold (g/dL)Hb threshold (mmol/L)
Children (0.5–5.0 yrs)11.06.8
Children (5–12 yrs)11.57.1
Teens (12–15 yrs)12.07.4
Women, non-pregnant (>15yrs)12.07.4
Women, pregnant11.06.8
Men (>15yrs)13.08.1
A blood test will provide counts of white blood cells, red blood cells and platelets. If anemia appears, further tests may determine what type it is, and whether it has a serious cause. although of that, it is possible to refer to the genetic history and physical diagnosis.[63] These tests may also include serum ferritin, iron studies, vitamin B12, genetic testing, and a bone marrow sample, if needed.[64] [65]

Reticulocyte counts, and the "kinetic" approach to anemia, have become more common than in the past in the large medical centers of the United States and some other wealthy nations, in part because some automatic counters now have the capacity to include reticulocyte counts. A reticulocyte count is a quantitative measure of the bone marrow's production of new red blood cells. The reticulocyte production index is a calculation of the ratio between the level of anemia and the extent to which the reticulocyte count has risen in response. If the degree of anemia is significant, even a "normal" reticulocyte count actually may reflect an inadequate response.If an automated count is not available, a reticulocyte count can be done manually following special staining of the blood film. In manual examination, activity of the bone marrow can also be gauged qualitatively by subtle changes in the numbers and the morphology of young RBCs by examination under a microscope. Newly formed RBCs are usually slightly larger than older RBCs and show polychromasia. Even where the source of blood loss is obvious, evaluation of erythropoiesis can help assess whether the bone marrow will be able to compensate for the loss and at what rate.

When the cause is not obvious, clinicians use other tests, such as: ESR, serum iron, transferrin, RBC folate level, hemoglobin electrophoresis, renal function tests (e.g. serum creatinine) although the tests will depend on the clinical hypothesis that is being investigated.

When the diagnosis remains difficult, a bone marrow examination allows direct examination of the precursors to red cells, although is rarely used as is painful, invasive and is hence reserved for cases where severe pathology needs to be determined or excluded.

Red blood cell size

In the morphological approach, anemia is classified by the size of red blood cells; this is either done automatically or on microscopic examination of a peripheral blood smear. The size is reflected in the mean corpuscular volume (MCV). If the cells are smaller than normal (under 80 fl), the anemia is said to be microcytic; if they are normal size (80–100 fl), normocytic; and if they are larger than normal (over 100 fl), the anemia is classified as macrocytic. This scheme quickly exposes some of the most common causes of anemia; for instance, a microcytic anemia is often the result of iron deficiency. In clinical workup, the MCV will be one of the first pieces of information available, so even among clinicians who consider the "kinetic" approach more useful philosophically, morphology will remain an important element of classification and diagnosis.Limitations of MCV include cases where the underlying cause is due to a combination of factors – such as iron deficiency (a cause of microcytosis) and vitamin B12 deficiency (a cause of macrocytosis) where the net result can be normocytic cells.

Production vs. destruction or loss

The "kinetic" approach to anemia yields arguably the most clinically relevant classification of anemia. This classification depends on evaluation of several hematological parameters, particularly the blood reticulocyte (precursor of mature RBCs) count. This then yields the classification of defects by decreased RBC production versus increased RBC destruction or loss. Clinical signs of loss or destruction include abnormal peripheral blood smear with signs of hemolysis; elevated LDH suggesting cell destruction; or clinical signs of bleeding, such as guaiac-positive stool, radiographic findings, or frank bleeding.The following is a simplified schematic of this approach:

Here is a schematic representation of how to consider anemia with MCV as the starting point:

Other characteristics visible on the peripheral smear may provide valuable clues about a more specific diagnosis; for example, abnormal white blood cells may point to a cause in the bone marrow.

Microcytic

See main article: Microcytic anemia. Microcytic anemia is primarily a result of hemoglobin synthesis failure/insufficiency, which could be caused by several etiologies:Iron-deficiency anemia is the most common type of anemia overall and it has many causes. RBCs often appear hypochromic (paler than usual) and microcytic (smaller than usual) when viewed with a microscope.

The Mentzer index (mean cell volume divided by the RBC count) predicts whether microcytic anemia may be due to iron deficiency or thalassemia, although it requires confirmation.[72]

Macrocytic

See main article: Macrocytic anemia.

Macrocytic anemia can be further divided into "megaloblastic anemia" or "nonmegaloblastic macrocytic anemia". The cause of megaloblastic anemia is primarily a failure of DNA synthesis with preserved RNA synthesis, which results in restricted cell division of the progenitor cells. The megaloblastic anemias often present with neutrophil hypersegmentation (six to 10 lobes). The nonmegaloblastic macrocytic anemias have different etiologies (i.e. unimpaired DNA globin synthesis,) which occur, for example, in alcoholism.In addition to the nonspecific symptoms of anemia, specific features of vitamin B12 deficiency include peripheral neuropathy and subacute combined degeneration of the cord with resulting balance difficulties from posterior column spinal cord pathology.[74] Other features may include a smooth, red tongue and glossitis.The treatment for vitamin B12-deficient anemia was first devised by William Murphy, who bled dogs to make them anemic, and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and George Whipple then set about to isolate the curative substance chemically and ultimately were able to isolate the vitamin B12 from the liver. All three shared the 1934 Nobel Prize in Medicine.[75]

Normocytic

See main article: Normocytic anemia. Normocytic anemia occurs when the overall hemoglobin levels are decreased, but the red blood cell size (mean corpuscular volume) remains normal. Causes include:

Dimorphic

A dimorphic appearance on a peripheral blood smear occurs when there are two simultaneous populations of red blood cells, typically of different size and hemoglobin content (this last feature affecting the color of the red blood cell on a stained peripheral blood smear). For example, a person recently transfused for iron deficiency would have small, pale, iron deficient red blood cells (RBCs) and the donor RBCs of normal size and color. Similarly, a person transfused for severe folate or vitamin B12 deficiency would have two cell populations, but, in this case, the patient's RBCs would be larger and paler than the donor's RBCs.

A person with sideroblastic anemia (a defect in heme synthesis, commonly caused by alcoholism, but also drugs/toxins, nutritional deficiencies, a few acquired and rare congenital diseases) can have a dimorphic smear from the sideroblastic anemia alone. Evidence for multiple causes appears with an elevated RBC distribution width (RDW), indicating a wider-than-normal range of red cell sizes, also seen in common nutritional anemia.

Heinz body anemia

Heinz bodies form in the cytoplasm of RBCs and appear as small dark dots under the microscope. In animals, Heinz body anemia has many causes. It may be drug-induced, for example in cats and dogs by acetaminophen (paracetamol), or may be caused by eating various plants or other substances:

Hyperanemia

Hyperanemia is a severe form of anemia, in which the hematocrit is below 10%.[79]

Refractory anemia

Refractory anemia, an anemia which does not respond to treatment,[80] is often seen secondary to myelodysplastic syndromes.[81] Iron-deficiency anemia may also be refractory as a manifestation of gastrointestinal problems which disrupt iron absorption or cause occult bleeding.[82]

Transfusion dependent

Transfusion dependent anemia is a form of anemia where ongoing blood transfusion are required.[83] Most people with myelodysplastic syndrome develop this state at some point in time. Beta thalassemia may also result in transfusion dependence.[84] [85] Concerns from repeated blood transfusions include iron overload.[86] This iron overload may require chelation therapy.[87]

Treatment

The global market for anemia treatments is estimated at more than USD 23 billion per year and is fast growing because of the rising prevalence and awareness of anemia. The types of anemia treated with drugs are iron-deficiency anemia, thalassemia, aplastic anemia, hemolytic anemia, sickle cell anemia, and pernicious anemia, the most important of them being deficiency and sickle cell anemia with together 60% of market share because of highest prevalence as well as higher treatment costs compared with other types.[12] Treatment for anemia depends on cause and severity. Vitamin supplements given orally (folic acid or vitamin B12) or intramuscularly (vitamin B12) will replace specific deficiencies.[1]

Apart from that, iron supplements, antibiotics, immunosuppressant, bone marrow stimulants, corticosteroids, gene therapy and iron chelating agents are forms of anemia treatment drugs, with immunosuppressants and corticosteroids accounting for 58% of the market share. A paradigm shift towards gene therapy and monoclonal antibody therapies is observed.[12]

Oral iron

Nutritional iron deficiency is common in developing nations. An estimated two-thirds of children and of women of childbearing age in most developing nations are estimated to have iron deficiency without anemia with one-third of them having an iron deficiency with anemia.[88] Iron deficiency due to inadequate dietary iron intake is rare in men and postmenopausal women. The diagnosis of iron deficiency mandates a search for potential sources of blood loss, such as gastrointestinal bleeding from ulcers or colon cancer.

Mild to moderate iron-deficiency anemia is treated by oral iron supplementation with ferrous sulfate, ferrous fumarate, or ferrous gluconate. Daily iron supplements have been shown to be effective in reducing anemia in women of childbearing age.[89] When taking iron supplements, stomach upset or darkening of the feces are commonly experienced. The stomach upset can be alleviated by taking the iron with food; however, this decreases the amount of iron absorbed. Vitamin C aids in the body's ability to absorb iron, so taking oral iron supplements with orange juice is of benefit.[90]

In the anemia of chronic kidney disease, recombinant erythropoietin or epoetin alfa is recommended to stimulate RBC production, and if iron deficiency and inflammation are also present, concurrent parenteral iron is also recommended.[91]

Injectable iron

In cases where oral iron has either proven ineffective, would be too slow (for example, pre-operatively), or where absorption is impeded (for example in cases of inflammation), parenteral iron preparations can be used. Parenteral iron can improve iron stores rapidly and is also effective for treating people with postpartum haemorrhage, inflammatory bowel disease, and chronic heart failure.[92] The body can absorb up to 6 mg iron daily from the gastrointestinal tract. In many cases, the patient has a deficit of over 1,000 mg of iron which would require several months to replace. This can be given concurrently with erythropoietin to ensure sufficient iron for increased rates of erythropoiesis.[93]

Blood transfusions

Blood transfusions in those without symptoms is not recommended until the hemoglobin is below 60 to 80 g/L (6 to 8 g/dL). In those with coronary artery disease who are not actively bleeding transfusions are only recommended when the hemoglobin is below 70 to 80g/L (7 to 8 g/dL).[9] Transfusing earlier does not improve survival.[94] Transfusions otherwise should only be undertaken in cases of cardiovascular instability.[95]

A 2012 review concluded that when considering blood transfusions for anaemia in people with advanced cancer who have fatigue and breathlessness (not related to cancer treatment or haemorrhage), consideration should be given to whether there are alternative strategies can be tried before a blood transfusion.[96]

Vitamin B12 intramuscular injections

In many cases, vitamin B12 is used by intramuscular injection in severe cases or cases of malabsorption of dietary-B12. Pernicious anemia caused by loss of intrinsic factor cannot be prevented.[97] If there are other, reversible causes of low vitamin B12 levels, the cause must be treated.[98]

Vitamin B12 deficiency anemia is usually easily treated by providing the necessary level of vitamin B12 supplementation.[99] The injections are quick-acting, and symptoms usually go away within one to two weeks. As the condition improves, doses are reduced to weeks and then can be given monthly. Intramuscular therapy leads to more rapid improvement and should be considered in patients with severe deficiency or severe neurologic symptoms. Treatment should begin rapidly for severe neurological symptoms, as some changes can become permanent.[100] In some individuals lifelong treatment may be needed.

Erythropoiesis-stimulating agents

The objective for the administration of an erythropoiesis-stimulating agent (ESA) is to maintain hemoglobin at the lowest level that both minimizes transfusions and meets the individual person's needs.[101] They should not be used for mild or moderate anemia.[94] They are not recommended in people with chronic kidney disease unless hemoglobin levels are less than 10 g/dL or they have symptoms of anemia. Their use should be along with parenteral iron.[101] The 2020 Cochrane Anaesthesia Review Group review of erythropoietin (EPO) plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery [102] demonstrated that patients were much less likely to require red cell transfusion and in those transfused, the volumes were unchanged (mean difference -0.09, 95% CI -0.23 to 0.05). Pre-operative hemoglobin concentration was increased in those receiving 'high dose' EPO, but not 'low dose'.

Hyperbaric oxygen

Treatment of exceptional blood loss (anemia) is recognized as an indication for hyperbaric oxygen (HBO) by the Undersea and Hyperbaric Medical Society.[103] [104] The use of HBO is indicated when oxygen delivery to tissue is not sufficient in patients who cannot be given blood transfusions for medical or religious reasons. HBO may be used for medical reasons when threat of blood product incompatibility or concern for transmissible disease are factors.[103] The beliefs of some religions (ex: Jehovah's Witnesses) may require they use the HBO method.[103] A 2005 review of the use of HBO in severe anemia found all publications reported positive results.[105]

Preoperative anemia

An estimated 30% of adults who require non-cardiac surgery have anemia.[106] In order to determine an appropriate preoperative treatment, it is suggested that the cause of anemia be first determined.[107] There is moderate level medical evidence that supports a combination of iron supplementation and erythropoietin treatment to help reduce the requirement for red blood cell transfusions after surgery in those who have preoperative anemia.[106]

Epidemiology

Anemia affects 27% of the world's population with iron-deficiency anemia accounting for more than 60% of it.[108] A moderate degree of iron-deficiency anemia affected approximately 610 million people worldwide or 8.8% of the population.[13] It is somewhat more common in females (9.9%) than males (7.8%).[13] Mild iron-deficiency anemia affects another 375 million.[13] Severe anaemia is prevalent globally, and especially in sub-Saharan Africa[109] where it is associated with infections including malaria and invasive bacterial infections.[110]

History

Signs of severe anemia in human bones from 4000 years ago have been uncovered in Thailand.[111]

External links

[About Anemia]

Notes and References

  1. Janz TG, Johnson RL, Rubenstein SD. Anemia in the emergency department: evaluation and treatment . Emergency Medicine Practice . 15 . 11 . 1–15; quiz 15–16 . November 2013 . 24716235 .
  2. Web site: Anemia: Practice Essentials, Pathophysiology, Etiology . 8 February 2022 . 9 November 2021.
  3. Web site: Anemia NHLBI, NIH . www.nhlbi.nih.gov . 8 February 2022.
  4. Web site: anaemia. Dictionary.com. 7 July 2014. live. https://web.archive.org/web/20140714223241/http://dictionary.reference.com/browse/anaemia. 14 July 2014.
  5. Web site: Anemia - Symptoms and causes . 2022-04-01 . Mayo Clinic . en.
  6. Smith RE . The clinical and economic burden of anemia . The American Journal of Managed Care . 16 Suppl Issues . S59–66 . March 2010 . 20297873 .
  7. Book: Rhodes . Carl E. . Denault . Deanna . Varacallo . Matthew . StatPearls . 2024 . StatPearls Publishing . Physiology, Oxygen Transport . 30855920 .
  8. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, Webb P, Lartey A, Black RE . 11748341 . Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? . Lancet . 382 . 9890 . 452–477 . August 2013 . 23746776 . 10.1016/S0140-6736(13)60996-4 .
  9. Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P . Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians . Annals of Internal Medicine . 159 . 11 . 770–779 . December 2013 . 24297193 . 10.7326/0003-4819-159-11-201312030-00009 . 4712203 .
  10. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . Lancet . 388 . 10053 . 1545–1602 . October 2016 . 27733282 . 5055577 . 10.1016/S0140-6736(16)31678-6 . Vos . Theo . Allen . Christine . Arora . Megha . Barber . Ryan M. . Bhutta . Zulfiqar A. . Brown . Alexandria . Carter . Austin . Casey . Daniel C. . Charlson . Fiona J. . Chen . Alan Z. . Coggeshall . Megan . Cornaby . Leslie . Dandona . Lalit . Dicker . Daniel J. . Dilegge . Tina . Erskine . Holly E. . Ferrari . Alize J. . Fitzmaurice . Christina . Fleming . Tom . Forouzanfar . Mohammad H. . Fullman . Nancy . Gething . Peter W. . Goldberg . Ellen M. . Graetz . Nicholas . Haagsma . Juanita A. . Hay . Simon I. . Johnson . Catherine O. . Kassebaum . Nicholas J. . Kawashima . Toana . Kemmer . Laura . 1 .
  11. Peyrin-Biroulet . Laurent . Williet . Nicolas . Cacoub . Patrice . Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review . The American Journal of Clinical Nutrition . 1 December 2015 . 102 . 6 . 1585–1594 . 10.3945/ajcn.114.103366 . 26561626 . free .
  12. 2019-04-26 . Anemia Treatment Drugs: 2019 Global Market Study; Analyzed by Type of Anemia, Type of Drug, and Geography . 2023-08-02 . GlobeNewswire.
  13. Vos T . etal . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 . Lancet . 380 . 9859 . 2163–2196 . December 2012 . 23245607 . 6350784 . 10.1016/S0140-6736(12)61729-2 .
  14. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 . Lancet . 385 . 9963 . 117–71 . January 2015 . 25530442 . 4340604 . 10.1016/S0140-6736(14)61682-2 . ((GBD 2013 Mortality Causes of Death Collaborators)).
  15. Web site: WHO Global Anaemia estimates, 2021 Edition . Wolrd Health Organization. 27 February 2022.
  16. Web site: WHO Interventions by global target. https://web.archive.org/web/20160814083405/http://www.who.int/elena/global-targets/en/ . dead . August 14, 2016 . www.who.int . World Health Organization.
  17. Web site: 14 June 2016. Devex. The case for action on anemia.
  18. Web site: Exercising With Anemia: Prescription for Health. 2022-01-08. Medscape. en.
  19. Weckmann . Gesine . Kiel . Simone . Chenot . Jean-François . Angelow . Aniela . 2023-01-24 . Association of Anemia with Clinical Symptoms Commonly Attributed to Anemia - Analysis of Two Population-Based Cohorts . Journal of Clinical Medicine . English . 12 . 3 . 921 . 10.3390/jcm12030921 . 36769569 . 9918126 . free .
  20. Web site: 2022-03-24 . What Are Symptoms of Anemia? . 2022-06-26 . National Heart, Lung, and Blood Institute..
  21. Web site: Anemia . 2022-01-08 . www.hematology.org . en.
  22. Stevens . Gretchen A . Finucane . Mariel M . De-Regil . Luz Maria . Paciorek . Christopher J . Flaxman . Seth R . Branca . Francesco . Peña-Rosas . Juan Pablo . Bhutta . Zulfiqar A . Ezzati . Majid . Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data . The Lancet Global Health . July 2013 . 1 . 1 . e16–e25 . 10.1016/s2214-109x(13)70001-9 . 4547326 . 25103581.
  23. Balarajan . Yarlini . Ramakrishnan . Usha . Özaltin . Emre . Shankar . Anuraj H . Subramanian . Sv . Anaemia in low-income and middle-income countries . The Lancet . December 2011 . 378 . 9809 . 2123–2135 . 10.1016/s0140-6736(10)62304-5 . 21813172 .
  24. Haas . Jere D. . Brownlie . Thomas . 2001-02-01 . Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship . The Journal of Nutrition . 131 . 2 . 676S–690S . 10.1093/jn/131.2.676s . 11160598 . free .
  25. De Franceschi . Lucia . Iolascon . Achille . Taher . Ali . Cappellini . Maria Domenica . Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment . European Journal of Internal Medicine . July 2017 . 42 . 16–23 . 10.1016/j.ejim.2017.04.018 . 28528999 .
  26. Book: Weksler . Babette . Wintrobe's Atlas of Clinical Hematology . 2017 . Lippincott Williams & Wilkins . 9781451154542 . PT105 . en.
  27. Web site: Mental Health and Pica . 2022-04-26 . WebMD . en.
  28. Allen . Richard P. . Auerbach . Sarah . Bahrain . Huzefa . Auerbach . Michael . Earley . Christopher J. . The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia . American Journal of Hematology . April 2013 . 88 . 4 . 261–264 . 10.1002/ajh.23397 . 23494945 . 35587006 . free .
  29. Table 12-1 in: Book: Mitchell . Richard Sheppard . Kumar . Vinay . Abbas . Abul K. . Fausto . Nelson . Robbins Basic Pathology . Saunders . Philadelphia . 2007. 978-1-4160-2973-1 . 8th.
  30. Book: Gregg. XT. Prchal. JT. Williams Hermatology. 2007. McGraw-Hill. Anemia of Endocrine Disorders.
  31. Web site: the definition of leukoerythroblastosis. www.dictionary.com. en. 2018-12-02. 2 December 2018. https://web.archive.org/web/20181202070610/https://www.dictionary.com/browse/leukoerythroblastosis. dead.
  32. Web site: Overview of hemolytic anemias in children . Despotovic . J . Mahoney . D . Armsby . C . UpToDate. 2021 . The Lecturio Medical Concept Library . 28 June 2021.
  33. Book: Capriotti, Theresa. Pathophysiology : introductory concepts and clinical perspectives. Frizzell, Joan Parker. 2016. 978-0-8036-1571-7. Philadelphia. 900626405.
  34. Book: Mitchell . Richard Sheppard . Kumar . Vinay . Abbas . Abul K. . Fausto . Nelson . Robbins Basic Pathology . Saunders . Philadelphia . 432 . 978-1-4160-2973-1 . 8th . 2007 .
  35. Book: Cotran . Ramzi S. . Kumar . Vinay . Fausto . Nelson . Robbins . Stanley L. . Abbas . Abul K. . Robbins and Cotran pathologic basis of disease . Elsevier Saunders . St. Louis, Mo . 2005 . 637 . 978-0-7216-0187-8 .
  36. http://www.trcc.org/blood/10b_autoimmune.pdf "Autoimmune Hemolytic Anemia (AIHA)"
  37. Berentsen S, Beiske K, Tjønnfjord GE . Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy . Hematology . 12 . 5 . 361–370 . October 2007 . 17891600 . 2409172 . 10.1080/10245330701445392 .
  38. Stijlemans . Benoît . Guilliams . Martin . Raes . Geert . Beschin . Alain . Magez . Stefan . De Baetselier . Patrick . African trypanosomosis: From immune escape and immunopathology to immune intervention . Veterinary Parasitology . August 2007 . 148 . 1 . 3–13 . 10.1016/j.vetpar.2007.05.005 . 17560035 .
  39. Web site: Do Hemorrhoids Cause Iron Deficiency Anemia? . 26 June 2018 .
  40. Brooker S, Hotez PJ, Bundy DA . Hookworm-related anaemia among pregnant women: a systematic review . PLOS Neglected Tropical Diseases . 2 . 9 . e291 . September 2008 . 18820740 . 2553481 . 10.1371/journal.pntd.0000291 . free .
  41. Gyorkos TW, Gilbert NL, Larocque R, Casapía M . Trichuris and hookworm infections associated with anaemia during pregnancy . Tropical Medicine & International Health . 16 . 4 . 531–537 . April 2011 . 21281406 . 10.1111/j.1365-3156.2011.02727.x . 205391965 .
  42. Whitehead . Nedra S. . Williams . Laurina O. . Meleth . Sreelatha . Kennedy . Sara M. . Ubaka-Blackmoore . Nneka . Geaghan . Sharon M. . Nichols . James H. . Carroll . Patrick . McEvoy . Michael T. . Gayken . Julie . Ernst . Dennis J. . Litwin . Christine . Epner . Paul . Taylor . Jennifer . Graber . Mark L. . Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review . Critical Care . December 2019 . 23 . 1 . 278 . 10.1186/s13054-019-2511-9 . 31399052 . 6688222 . free .
  43. Martin . Niels D. . Scantling . Dane . Hospital-Acquired Anemia: A Contemporary Review of Etiologies and Prevention Strategies . Journal of Infusion Nursing . September 2015 . 38 . 5 . 330–338 . 10.1097/NAN.0000000000000121 . 26339939 . 30859103 .
  44. Bellotto . Fabio . Cati . Arianna . Anemia ed ischemia miocardica: relazioni ed interferenze . Anemia and myocardial ischemia: relationships and interferences . it . Recenti Progressi in Medicina . March 2006 . 97 . 3 . 153–164 . 10.1701/121.1312 . 16700423 .
  45. Hung . Szu-Chun . Kuo . Ko-Lin . Peng . Ching-Hsiu . Wu . Che-Hsiung . Wang . Yi-Chun . Tarng . Der-Cherng . Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease . Journal of the American Heart Association . 2015 . 4 . 1 . e001480 . 10.1161/JAHA.114.001480 . 4330071 . 25559015.
  46. Book: Fluid imbalances. Portable Fluids and Electrolytes (Portable Series) . Lippincott Williams & Wilkins. Hagerstwon, MD . 2007 . 62 . 978-1-58255-678-9 .
  47. Web site: ISBT: 8. Obstetric anaemia. www.isbtweb.org. en. 2018-05-22.
  48. Verma S, Cherayil BJ . Iron and inflammation - the gut reaction . Metallomics . 9 . 2 . 101–111 . February 2017 . 28067386 . 5321802 . 10.1039/c6mt00282j . Review .
  49. Guagnozzi D, Lucendo AJ . Anemia in inflammatory bowel disease: a neglected issue with relevant effects . World Journal of Gastroenterology . 20 . 13 . 3542–3551 . April 2014 . 24707137 . 3974521 . 10.3748/wjg.v20.i13.3542 . Review . free .
  50. Stein J, Connor S, Virgin G, Ong DE, Pereyra L . Anemia and iron deficiency in gastrointestinal and liver conditions . World Journal of Gastroenterology . 22 . 35 . 7908–7925 . September 2016 . 27672287 . 5028806 . 10.3748/wjg.v22.i35.7908 . Review . free .
  51. Leffler . Daniel A. . Green . Peter H. R. . Fasano . Alessio . Extraintestinal manifestations of coeliac disease . Nature Reviews Gastroenterology & Hepatology . October 2015 . 12 . 10 . 561–571 . 10.1038/nrgastro.2015.131 . 26260366 . 15561525 .
  52. Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vécsei A, Volta U, Zevallos V, Sapone A, Fasano A . Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders . Nutrients . 5 . 10 . 3839–3853 . September 2013 . 24077239 . 3820047 . 10.3390/nu5103839 . Review . free .
  53. James . Stephen P. . National Institutes of Health Consensus Development Conference statement on Celiac Disease, June 28–30, 2004 . Gastroenterology . April 2005 . 128 . 4 . S1–S9 . 10.1053/j.gastro.2005.02.007 . 15825115 .
  54. Lomer MC . Dietary and nutritional considerations for inflammatory bowel disease . The Proceedings of the Nutrition Society . 70 . 3 . 329–335 . August 2011 . 21450124 . 10.1017/S0029665111000097 . Review . free .
  55. Gerasimidis K, McGrogan P, Edwards CA . The aetiology and impact of malnutrition in paediatric inflammatory bowel disease . Journal of Human Nutrition and Dietetics . 24 . 4 . 313–326 . August 2011 . 21564345 . 10.1111/j.1365-277X.2011.01171.x . Review . free .
  56. Beutler E, Waalen J . The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? . Blood . 107 . 5 . 1747–1750 . March 2006 . 16189263 . 1895695 . 10.1182/blood-2005-07-3046 .
  57. Book: Rodak, Bernadette F.. Hematology: Clinical Principles and Applications. 2007. Saunders. 978-1-4160-3006-5. 3rd. Philadelphia. 220. https://web.archive.org/web/20160425061405/https://books.google.com/books?id=6sfacydDNsUC&pg=PA220. 2016-04-25. live.
  58. Book: Albert J. . Pomeranz . Svapna . Sabnis . Sharon . Busey . Robert M. . Kliegman . 2016 . Pediatric Decision-Making Strategies . 2nd . Elsevier . 978-0-323-29854-4 .
  59. Book: Polin. Richard A.. Abman. Steven H.. Rowitch. David. Benitz. William E. . Fetal and Neonatal Physiology. 2016. Elsevier Health Sciences. 978-0-323-35232-1 . 1085. 5. live. https://web.archive.org/web/20161031150823/https://books.google.com/books?id=JootDAAAQBAJ&pg=PA1085. 2016-10-31.
  60. Book: Uthman. Ed . Understanding Anemia. 2009. Univ. Press of Mississippi. 978-1-60473-701-1. 23. live. https://web.archive.org/web/20161031150408/https://books.google.com/books?id=2yBl75DJ8_kC&pg=PA23. 2016-10-31.
  61. Book: Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity . 2011 . World Health Organization . 10665/85839 . free . Organization . World Health .
  62. Book: World Health Organization . Worldwide prevalence of anaemia 1993–2005 . 2008 . 978-92-4-159665-7 . 2009-03-25 . World Health Organization . Geneva. https://web.archive.org/web/20090312111339/http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. 12 March 2009 . live.
  63. Web site: Anemia. 2021-10-11. Radiologyinfo.org. en.
  64. Web site: How Anemia Is Diagnosed and Treated . 2021-10-11 . WebMD . en.
  65. Web site: Anemia Types, Treatment, Symptoms, Signs, Causes & Iron Deficiency . 2021-10-11 . eMedicineHealth . en.
  66. https://www.cdc.gov/nccdphp/dnpa/nutrition/nutrition_for_everyone/iron_deficiency/index.htm Recommendations to Prevent and Control Iron Deficiency in the United States
  67. Iron Deficiency – United States, 1999–2000. MMWR. October 11, 2002. 51. 40. 897–899. 12418542. 21 April 2012. live. https://web.archive.org/web/20120505040540/http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5140a1.htm. 5 May 2012. Centers for Disease Control Prevention (CDC).
  68. Web site: Global Iron-Deficiency Anemia Therapy Market – Industry Trends and Forecast to 2027 - . 2023-08-02 . Data Bridge Market Research.
  69. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG . 33404386 . Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States . Pediatrics . 107 . 6 . 1381–1386 . June 2001 . 11389261 . 10.1542/peds.107.6.1381 .
  70. Grantham-McGregor S, Ani C . A review of studies on the effect of iron deficiency on cognitive development in children . The Journal of Nutrition . 131 . 2S–2 . 649S–666S; discussion 666S–668S . February 2001 . 11160596 . 10.1093/jn/131.2.649S . free .
  71. Web site: Iron Deficiency Anaemia: Assessment, Prevention, and Control: A guide for programme managers . 2010-08-24 . dead. https://web.archive.org/web/20110516122938/http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf . 2011-05-16 .
  72. Mentzer WC . Differentiation of iron deficiency from thalassaemia trait . Lancet . 1 . 7808 . 882 . April 1973 . 4123424 . 10.1016/s0140-6736(73)91446-3 .
  73. Long . Brit . Koyfman . Alex . Emergency Medicine Evaluation and Management of Anemia . Emergency Medicine Clinics of North America . August 2018 . 36 . 3 . 609–630 . 10.1016/j.emc.2018.04.009 . 30037447 .
  74. http://www.emedicine.com/NEURO/topic439.htm eMedicine – "Vitamin B-12 Associated Neurological Diseases": Article by Niranjan N Singh
  75. Web site: Physiology or Medicine 1934 – Presentation Speech . Nobelprize.org . 1934-12-10 . 2010-08-24. https://web.archive.org/web/20100828134134/http://nobelprize.org/nobel_prizes/medicine/laureates/1934/press.html. 28 August 2010 . live.
  76. Book: Hovda. L. Brutlag. A. Poppenga. RH. Peterson. K . Blackwell's Five-Minute Veterinary Consult Clinical Companion: Small Animal Toxicology. 2016. John Wiley & Sons. 978-1-119-03652-4. 515–520. 2nd. Chapter 69: Onions and garlic.
  77. Book: Harvey. John W. . Veterinary hematology: a diagnostic guide and color atlas. 2012. Elsevier/Saunders. St. Louis, MO. 978-1-4377-0173-9. 104.
  78. Book: 10.1016/B978-1-4557-4555-5.00117-5 . Hemolytic Disorders . Robinson's Current Therapy in Equine Medicine . 2015 . 492–495 . 978-1-4557-4555-5 . Peek SF .
  79. Wallerstein RO . Laboratory evaluation of anemia . The Western Journal of Medicine . 146 . 4 . 443–451 . April 1987 . 3577135 . 1307333 .
  80. Web site: MedTerms Definition: Refractory Anemia . Medterms.com . 2011-04-27 . 2011-10-31 . live. https://web.archive.org/web/20111208232310/http://www.medterms.com/script/main/art.asp?articlekey=5275 . 2011-12-08 .
  81. Web site: Good Source for later . Atlasgeneticsoncology.org . 2011-10-31 . live. https://web.archive.org/web/20111103180817/http://atlasgeneticsoncology.org/Anomalies/RAID1104.html . 2011-11-03 .
  82. Mody RJ, Brown PI, Wechsler DS . 38832868 . Refractory iron deficiency anemia as the primary clinical manifestation of celiac disease . Journal of Pediatric Hematology/Oncology . 25 . 2 . 169–172 . February 2003 . 12571473 . 10.1097/00043426-200302000-00018 .
  83. Gale RP, Barosi G, Barbui T, Cervantes F, Dohner K, Dupriez B, Gupta V, Harrison C, Hoffman R, Kiladjian JJ, Mesa R, Mc Mullin MF, Passamonti F, Ribrag V, Roboz G, Saglio G, Vannucchi A, Verstovsek S . 6 . What are RBC-transfusion-dependence and -independence? . Leukemia Research . 35 . 1 . 8–11 . January 2011 . 20692036 . 10.1016/j.leukres.2010.07.015 . 8215731 .
  84. Book: Hillyer . Christopher D. . Silberstein . Leslie E. . Ness . Paul M. . Anderson . Kenneth C. . Roback . John D. . Blood Banking and Transfusion Medicine: Basic Principles and Practice . 2006 . Elsevier Health Sciences . 9780702036255 . 534 .
  85. Book: Mandel . Jess . Taichman . Darren . Pulmonary Vascular Disease . 2006 . Elsevier Health Sciences . 978-1416022466 . 170 . en.
  86. Melchert M, List AF . Management of RBC-transfusion dependence . Hematology. American Society of Hematology. Education Program . 2007 . 398–404 . 2007 . 18024657 . 10.1182/asheducation-2007.1.398 . free .
  87. Book: Ferri . Fred F. . BOPOD – Ferri's Clinical Advisor 2016 . 2015 . Elsevier Health Sciences . 978-0323378222 . 1131.e2 . en.
  88. West CE . Strategies to control nutritional anemia . The American Journal of Clinical Nutrition . 64 . 5 . 789–790 . November 1996 . 8901803 . 10.1093/ajcn/64.5.789. free .
  89. Low . MS . Speedy . J . Styles . CE . De-Regil . LM . Pasricha . SR . Daily iron supplementation for improving anaemia, iron status and health in menstruating women. . The Cochrane Database of Systematic Reviews . 18 April 2016 . 2016 . 4 . CD009747 . 10.1002/14651858.CD009747.pub2 . 27087396. 10182438 .
  90. Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M . Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients . Artificial Organs . 26 . 4 . 366–370 . April 2002 . 11952508 . 10.1046/j.1525-1594.2002.06888.x .
  91. Web site: Anaemia management in people with chronic kidney disease | Guidance and guidelines | NICE . 9 February 2011 . 2013-08-09 . live. https://web.archive.org/web/20130624124919/http://guidance.nice.org.uk/CG114/Guidance/pdf/English . 2013-06-24 .
  92. Ng . Oliver . Keeler . Barrie D . Mishra . Amitabh . Simpson . J A . Neal . Keith . Al-Hassi . Hafid Omar . Brookes . Matthew J . Acheson . Austin G . 7 December 2019 . Iron therapy for preoperative anaemia . Cochrane Database of Systematic Reviews . 2019 . 12 . CD011588 . 10.1002/14651858.CD011588.pub3 . 6899074 . 31811820.
  93. Auerbach M, Ballard H . Clinical use of intravenous iron: administration, efficacy, and safety . Hematology. American Society of Hematology. Education Program . 2010 . 338–347 . 2010 . 21239816 . 10.1182/asheducation-2010.1.338 . free .
  94. Kansagara D, Dyer E, Englander H, Fu R, Freeman M, Kagen D . Treatment of anemia in patients with heart disease: a systematic review . Annals of Internal Medicine . 159 . 11 . 746–757 . December 2013 . 24297191 . 10.7326/0003-4819-159-11-201312030-00007 . 27062899 .
  95. Goddard AF, James MW, McIntyre AS, Scott BB . Guidelines for the management of iron deficiency anaemia . Gut . 60 . 10 . 1309–1316 . October 2011 . 21561874 . 10.1136/gut.2010.228874 . British Society of Gastroenterology . free .
  96. Preston . Nancy J . Hurlow . Adam . Brine . Jennifer . Bennett . Michael I . Blood transfusions for anaemia in patients with advanced cancer . Cochrane Database of Systematic Reviews . 15 February 2012 . 2012 . 2 . CD009007 . 10.1002/14651858.CD009007.pub2 . 22336857 . 7388847 .
  97. Web site: Pernicious anemia: MedlinePlus Medical Encyclopedia . 2022-08-04 . medlineplus.gov . en.
  98. Book: Hankey, Graeme J. . Clinical neurology . 2008 . Manson . Joanna M. Wardlaw . 978-1-84076-518-2 . London . 503441695.
  99. Langan . Robert C. . Goodbred . Andrew J. . 2017-09-15 . Vitamin B12 Deficiency: Recognition and Management . American Family Physician . en-US . 96 . 6 . 384–389. 28925645 .
  100. Web site: 2017-09-14 . Pernicious Anemia Clinical Presentation: History, Physical Examination . 2022-08-04 . https://web.archive.org/web/20170914062810/http://emedicine.medscape.com/article/204930-clinical#b3 . 14 September 2017 . dead.
  101. Aapro MS, Link H . September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents . The Oncologist . 13 Suppl 3 . Supplement 3 . 33–36 . 2008 . 18458123 . 10.1634/theoncologist.13-S3-33 .
  102. Kaufner L, Heymann C . Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery . Cochrane Database of Systematic Reviews . 2020 . 2020 . 8 . CD012451 . 10.1002/14651858.CD012451.pub2 . 32790892 . 8095002 .
  103. Web site: Exceptional Blood Loss – Anemia . ((Undersea and Hyperbaric Medical Society)) . 2008-05-19 . dead. https://web.archive.org/web/20080705205816/http://www.uhms.org/ResourceLibrary/Indications/ExceptionalBloodLossAnemia/tabid/277/Default.aspx . July 5, 2008 .
  104. Hart GB, Lennon PA, Strauss MB . Hyperbaric oxygen in exceptional acute blood-loss anemia . J. Hyperbaric Med . 2 . 4 . 205–210 . 1987 . 2008-05-19 . usurped . https://web.archive.org/web/20090116015734/http://archive.rubicon-foundation.org/4352 . 2009-01-16 .
  105. Van Meter KW . A systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach . Undersea & Hyperbaric Medicine . 32 . 1 . 61–83 . 2005 . 15796315 . https://web.archive.org/web/20090116014923/http://archive.rubicon-foundation.org/4038 . usurped. 2009-01-16 .
  106. Kaufner . Lutz . von Heymann . Christian . Henkelmann . Anne . Pace . Nathan L . Weibel . Stephanie . Kranke . Peter . Meerpohl . Joerg J . Gill . Ravi . Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery . Cochrane Database of Systematic Reviews . 13 August 2020 . 2020 . 8 . CD012451 . 10.1002/14651858.CD012451.pub2 . 32790892 . 8095002 .
  107. Kotzé . Alwyn . Harris . Andrea . Baker . Charles . Iqbal . Tariq . Lavies . Nick . Richards . Toby . Ryan . Kate . Taylor . Craig . Thomas . Dafydd . British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia . British Journal of Haematology . November 2015 . 171 . 3 . 322–331 . 10.1111/bjh.13623 . 26343392 . 37709527 . free .
  108. The Global Burden of Anemia . 2016 . 30 . 2 . 247–308 . 10.1016/j.hoc.2015.11.002 . 27040955 . Kassebaum . Nicholas J. . ((GBD 2013 Anemia Collaborators)). Hematology/Oncology Clinics of North America . free .
  109. van Hensbroek . MB . Jonker . F . Bates . I . Severe acquired anaemia in Africa: new concepts. . British Journal of Haematology . September 2011 . 154 . 6 . 690–5 . 10.1111/j.1365-2141.2011.08761.x . 21707575. 205268648 .
  110. Abuga . KM . Muriuki . JM . Williams . TN . Atkinson . SH . How Severe Anaemia Might Influence the Risk of Invasive Bacterial Infections in African Children . International Journal of Molecular Sciences . 22 September 2020 . 21 . 18 . 6976 . 10.3390/ijms21186976 . 32972031. 7555399 . free .
  111. Tayles N . Anemia, genetic diseases, and malaria in prehistoric mainland Southeast Asia . American Journal of Physical Anthropology . 101 . 1 . 11–27 . September 1996 . 8876811 . 10.1002/(SICI)1096-8644(199609)101:1<11::AID-AJPA2>3.0.CO;2-G .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Anemia".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.